rat anti mouse lyve1 (R&D Systems)
Structured Review

Rat Anti Mouse Lyve1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 33 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+anti+mouse+lyve1/pm40108458-792-126-129?v=R%26D+Systems
Average 94 stars, based on 33 article reviews
Images
1) Product Images from "Dynamic cytoskeletal regulation of cell shape supports resilience of lymphatic endothelium."
Article Title: Dynamic cytoskeletal regulation of cell shape supports resilience of lymphatic endothelium.
Journal: Nature
doi: 10.1038/s41586-025-08724-6
Figure Legend Snippet: Fig. 1 | Junctional heterogeneity in capillary LECs. a, Whole-mount immunofluorescence of ear skin from a 25-week-old Cdh5-GFP mouse expressing VE-cadherin-GFP fusion protein (VE-cad). Boxed areas magnified below show unsegmented (arrows) and focal (arrowheads) VE-cadherin+ junctions in lymphatic capillary (left) and precollecting vessel (middle), and continuous zipper junctions in LYVE1− collecting vessel (right). b, Immunofluorescence in 12-week-old mouse ear skin showing VE-cadherin colocalization with CLDN5 at junctions. Line intensity profiles through lines 1 and 2 of respective stainings are depicted. c, Immunofluorescence at the indicated ages depicting junctional heterogeneity. Boxed areas are magnified. d,e, Quantification of lymphatic vessel sprouting (percentage of spiky ends of all lymphatic capillary ends, n = 7, 12 per respective stage, mean ± s.e.m.; d) and LEC proliferation (percentage Ki67+ of all LECs by flow cytometry, n = 3, 6, 8, 6 mice per respective stage, mean ± s.e.m.; e). f, Whole-mount silver nitrate (Ag) staining of ear dermis showing deposits around cell perimeter, including the lobe tips (arrow),
Techniques Used: Immunofluorescence, Expressing, Flow Cytometry, Staining
Figure Legend Snippet: Fig. 2 | Morphology and remodelling of intercellular overlaps between capillary LECs. a, Constructs for mosaic multicolour labelling of LECs using membrane-localized fluorescent proteins. b, Whole-mount immunofluorescence of mosaically labelled dermal LECs in a 6-week-old iMb2-Mosaic;Vegfr3-creERT2 mouse after 4-OHT treatment at 3 weeks, showing lobate shape in LYVE1+ capillaries and elongated shape in LYVE1− collectors (arrowheads). c, Whole-mount immunofluorescence of embryonic back skin (E17) or ear skin at indicated postnatal stages in iMb2-Mosaic;Vegfr3-creERT2 mice. d–f, Dermal LEC and vessel parameters, represented as mean ± s.d.: cell size (d, n = 24, 17 and 20 cells per respective stage), lobe number (e, n = 24, 48 and 20 cells per respective stage) and average lymphatic capillary width (f, n = 7, 5 and 9 mice per respective stage). Ordinary one-way ANOVA. g, Immunofluorescence of ear skin of a 12-week-old iMb2-Mosaic;Vegfr3-creERT2 mouse showing LYVE1 at LEC overlaps, with corresponding intensity plot. h, Double staining for cell surface and total LYVE1 (left), or with intradermally
Techniques Used: Construct, Membrane, Immunofluorescence, Double Staining
Figure Legend Snippet: Fig. 3 | Cytoskeletal organization in lobate capillary LECs. a, Dot plot showing differential expression of cytoskeletal genes between capillary and collecting vessel LECs. Dot size illustrates percentage of cells with transcript counts, colour illustrates average expression (log2-fold difference). Cap, lymphatic capillary; Col, collecting vessel. b, Whole-mount immunofluorescence of adult ear skin showing microtubule network in dermal capillary LECs. Cell outline, based on VE-cadherin and LYVE1 staining, in red. c, Quantification of microtubule (MT) anchoring and density in capillary LECs in 9–12-week-old mice. Cell outline from c in green, with MT endpoints shown by yellow (concave) and purple (convex) dots. Data represent the percentage of MT anchoring (left; n = 5 LECs from five mice, 20–53 MT per cell), or MTs per µm of cortex in concave (right; n = 156 MTs, 5 LECs from five mice) versus convex (n = 56 MTs, 5 LECs
Techniques Used: Quantitative Proteomics, Expressing, Immunofluorescence, Staining

